Brenda D. Gavin

Partner

Richard S. Kollender

Partner

Ira M. Lubert

Partner

P. Sherrill Neff

Partner

Adele Cirone Oliva

Partner

Matthew Rieke, M.D.

Partner

Geeta Vemuri, Ph.D.

Partner

David R. King

Venture Partner

Jamil M. Beg

Analyst
     
P. Sherrill Neff
  • Founding Partner of Quaker BioVentures
  • Previously: President, COO, and Director of Neose Technologies, a publicly traded life sciences company.  Senior VP, Corporate Development at U.S. Healthcare, a leading publicly traded HMO.  Managing Director in the investment banking division of Alex. Brown & Son.  Corporate attorney at Morgan, Lewis & Bockius.
  • Current Board Responsibilities: Amicus Therapeutics, Biolex Therapeutics, Neuronetics, Optherion and Regado Biosciences
  • Board Observer Responsibilities: Argolyn
  • Prior Board Participation: BioRexis Pharmaceutical Corporation and Medmark
  • Other: Former Chairman of the Greater Philadelphia Venture Group, Former President of the Pennsylvania Biotechnology Association.  Currently board member for Resource Capital Corporation (NYSE:RSO), University City Science Center, Biotechnology Institute, and the Policy Board of WXPN. Former board member of following publicly traded companies: Resource America, The Bancorp, Jefferson Bank, Neose Technologies. 
  • Education: B.A. from Wesleyan University and J.D. magna cum laude from the University of Michigan Law School

Copyright © 2003 Quaker BioVentures All Rights Reserved.